The Carlyle Group and GIC have sold a small portion of their combined stake in Brazil-based hospital network Rede D’Or, reducing it from 37.8% to 34%, via the company’s R$11.4b…
Health
-
-
Emerald Peak Appoints Lauren Burnhill as Managing Partner and Launches US$150m LatAm Fund
6 December 2020Emerald Peak Private Equity appointed Lauren Burnhill as a Managing Partner and launched its US$150m flagship America Impact Fund I, targeting opportunities in sectors that can best impact specific United…
-
Dux Capital Leads Investment in Atexto
14 January 2020DUX Capital led a follow-on investment in Atexto, a Mexican developer of chatbot technology for customer service applications, with participation from Redwood Ventures, Avalancha Ventures MC Capital, and others. (Press…
-
Criatec 3 Invests R$2.5m in NeuroUp (em português)
18 November 2019Criatec 3, managed by Inseed Investimentos, made a R$2.5m investment in NeuroUp, a Brazil-based wellness startup working on muscular biofeedback to address chronic pain. (Diario de Pernambuco) O fundo de…
-
Patricia Saenz (Mountain Nazca Colombia) and Paula Arango (Elevar Equity) Launch EWA Capital (en español)
7 September 2019Patricia Saenz (Mountain Nazca Colombia) and Paula Arango (Elevar Equity) joined forces to launch EWA Capital, a VC fund seeking US$30m to focus on investing in women entrepreneurs. (La República) …
-
Bain Capital will sell 10% of its stake in NotreDame Intermédica in a second follow on share offering following Intermédica’s IPO in 2018. The share offering is another partial exit…
-
BNDES announced investments in VC funds managed by A5, Axxon Group, Oria, Triaxis Capital, Trivella M3 Investimentos, Vox Capital and Fundepar. (BNDES) Serão priorizados investimentos com foco em infraestrutura, base…
-
Libbs Farmacêutica made a US$1m investment in Brazilian biotech PluriCell to develop regenerative cell therapies for cardiovascular diseases. PluriCell was founded in 2013 and incubated at USP/IPEN-Cietec. (Istoé Dinheiro) As…
-
Portuguese VC Indico Capital Partners made its inaugural Brazil investment in Zenklub, an online therapy and wellness platform. (DCI) A startup Zenklub recebeu R$ 2 milhões do fundo de investimentos…
-
Advent International announced that its portfolio company Grupo Biotoscana, a specialty pharmaceutical company in Latin America, priced its initial public offering at R$26.50 per share on Brazil’s B3 Exchange, generating…